In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00631072
Recruitment Status : Completed
First Posted : March 7, 2008
Last Update Posted : June 9, 2017
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Steven Balk, MD, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2014
  Actual Study Completion Date : April 2015